A widely used treatment for prostate cancer may cause more harm than good for some patients, according to Dr. Oliver Sartor, medical director of the Tulane Cancer Center.
Oct 23, 2014
4.4 / 5 (15) | 0
Western-led research has discovered that timing, in combination with aggression, are possible keys to long-term survival for patients with limited metastatic lung cancer.
Oct 24, 2014
not rated yet | 0